Learn how this new label-free method enables decision-making by providing insights into efficacy at the site of action, anticipating potential safety concerns, and supporting better clinical candidate selection.
Find us at Booth #49, during scientific posters presentations, and at our exclusive client reception!
This exciting implementation makes Aliri a one-stop-shop for the advanced GCP analysis of fluids and tissues
Using artificial intelligence and spatial biomarkers to detect the efficacy of immunotherapies
Aliri Celebrates 30 Years of Bioanalytical Excellence and Scientific Innovation during AAPS
Download Scientific Posters from AAPS
We were proud to present 11 scientific posters at the recent AAPS PharmSci 360 convention, featuring a range of advanced analytical best practices leveraging validated biomarkers, MALDI mass spectrometry imaging, spatial omics, and more.
LBA vs LC-MS: competing technologies at a development crossroad
Join bioanalytical experts Shane Karnik, MS, and Matt Hartle, PhD for an on-demand webinar to learn more about the changing market landscape, considerations for each technology, and when it makes sense to consider LC-MS over LBA for your next large molecule program.
Advancing your molecule with speed and agility
Take your program from discovery to clinic.
Our specialized team of industry experts and seasoned scientists provides support for your project from discovery through clinical development and NDA approval.
Building a successful bioanalysis strategy
When choosing the right CRO for your drug development journey, it’s essential to consider a partner who’s committed to bringing life-saving therapies to market with speed and regulatory compliance.
Our scientists at Aliri Bioanalysis help make drug products that result in better outcomes for patients.
Every day, our team at Aliri Bioanalysis focuses on getting high-quality data for our clients on drugs in development. As a CRO, our dynamic work demands innovative MS technology for solving the latest challenging problem. In each stage of the process, we dare to rewrite the rules of standard practice as we help make real products that affect the lives of others.
Aliri has been a pioneer in the development and application of bioanalytical and spatial multi-omics solutions for over 30 years, and we continue to be at the forefront of innovation today. Our seasoned team of scientists and technical experts provide a broad range of services and solutions that will help you to advance your molecule from discovery through clinical development and approval, while providing unmatched insights to de-risk your program and accelerated timelines to get you to your next milestone faster.

Aliri has the proven operational excellence across a range of traditional and cutting-edge technologies paired with the experience to support the unique needs of your development program.
Learn how you can utilize our team of dedicated scientists, program managers, quality specialists and industry experts.

Access quality data for filing your IND, NDA, or CTA with speed

Anticipate technical issues or potential roadblocks that may cause delays

Elucidate drug efficacy in the pertinent spatial context up to a cellular level, for more efficient and effective drug candidate evaluation and selection

Maximize the value of your drug discovery and development investments